Assetmark, Inc Alnylam Pharmaceuticals, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 9,186 shares of ALNY stock, worth $2.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,186

Previous 8,486 8.25%

Holding current value

$2.23 Million

Previous $2.06 Million 22.5%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$233.81 - $287.01 $163,667 - $200,907	700 Added 8.25%	9,186 $2.53 Million
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $129,695 - $223,535	905 Added 11.94%	8,486 $2.06 Million
Q1 2024 May 06, 2024	BUY	$146.51 - $198.2 $97,868 - $132,397	668 Added 9.66%	7,581 $1.13 Million
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $171,850 - $223,106	1,135 Added 19.64%	6,913 $1.32 Million
Q3 2023 Oct 27, 2023	BUY	$170.77 - $211.65 $159,499 - $197,681	934 Added 19.28%	5,778 $1.02 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $87,879 - $100,723	475 Added 10.87%	4,844 $920,000
Q1 2023 May 05, 2023	BUY	$182.66 - $235.53 $55,893 - $72,072	306 Added 7.53%	4,369 $875,000
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $235,808 - $306,705	1,271 Added 45.52%	4,063 $965,000
Q3 2022 Nov 01, 2022	BUY	$138.54 - $232.0 $386,803 - $647,744	2,792 New	2,792 $559,000
Q1 2020 May 12, 2020	SELL	$93.12 - $133.99 $8,939 - $12,863	-96 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $2,963 - $4,175	-45 Reduced 31.91%	96 $7,000
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $8,836 - $12,454	141 New	141 $10,000
Q1 2018 May 16, 2018	SELL	$115.92 - $148.54 $1,622 - $2,079	-14 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$114.49 - $139.98 $1,259 - $1,539	11 Added 366.67%	14 $2,000
Q3 2017 Nov 08, 2017	BUY	$72.53 - $118.27 $217 - $354	3	3 $0

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account